Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc lowers FY 2014 outlook-Conference Call


Thursday, 31 Jul 2014 08:00am EDT 

Valeant Pharmaceuticals International Inc:Sees FY 2014 revenue in the $8.0 to $8.3 billion range.FY 2014 cash EPS in the $7.90 to $8.10 per share range.FY 2014 revenue of $8.2 bln and EPS of $8.02 - Thomson Reuters I/B/E/S. 

Company Quote

210.42
1.03 +0.49%
24 Apr 2015